BOD Australia Health Care

$0.069 0.004 (6.15%)

High $0.07	Low $0.07	Trades 11	Turnover $3,477	Volume 53,435
30 June 2023 at 4:10pm

Register to track BOD and receive email alerts.

Market Cap (19-Sep) $4,256,112 (0th)	Close (30-Jun) $0.069 0 (0%)	Volume (30-Jun) 53,435	Shortsold (24-Oct) 1,681 (0.00%) (629th)
52w High $0.024	52w Low $0.024	P/E -	EPS -0.06

	Subject
	BOD BOD Ann: Bod announces progress in Aqua Phase PK Studies
	1 (current) 2 3
	BOD BOD Ann: BOD and Malaysian Antah Group sign Letter of Intent
	BOD BOD Ann: Updates regarding Aqua Phase Delivery Technology
	BOD BOD Ann: Quarterly Activities Report and Appendix 4C
	BOD BOD Ann: Change in Chairman's role
	BOD BOD Ann: Bod completes recruitment of Phase IIb clinical trial
	BOD BOD Ann: Aqua Phase PK Study submitted for ethics approval
	BOD BOD Ann: BOD reaches milestone in Schedule 3 CBD clinical trial
	BOD BOD Ann: Change of Director's Interest Notice - David Baker
	BOD BOD Ann: Grant of ASX Waiver
	BOD BOD Ann: Update on acquisition of Aqua Phase
	BOD BOD Ann: Bod Science establishes R&D funding facility
	BOD BOD Ann: Appendix 4D and Half Year Account
	BOD BOD Ann: Quarterly Activities Report and Appendix 4C
	BOD BOD Ann: Appointment of Company Secretary
	BOD BOD Ann: Notification of cessation of securities - BOD
	BOD BOD Ann: Bod Science receives $1.512 million R&D tax rebate
	BOD BOD Ann: Change of Director's Interest Notice - G Livery and A Bedi
	BOD BOD Ann: Notification of cessation of securities - BOD
	BOD BOD Ann: Change of Company Name to Bod Science Limited
	BOD BOD Ann: Appendix 3Y's - Baker, Livery, Patterson and Bedi
	BOD BOD Ann: Secton 708A cleansing notice
	BOD BOD Ann: Application for quotation of securities - BOD
	BOD BOD Ann: Bod secures licensing and supply agreement with Arrotex
	BOD BOD Ann: Notification regarding unquoted securities - BOD
	BOD BOD Ann: Notification regarding unquoted securities - BOD
	BOD BOD Ann: Results of Annual General Meeting
	BOD BOD Ann: Chief Executive Officer presentation to the 2022 AGM
	BOD BOD Ann: Bod Softgel offers outstanding bioavailability
	BOD BOD Ann: Final Director's Interest Notice
	BOD BOD Ann: Resignation of Director
	BOD BOD Ann: Annual Report to shareholders
	BOD BOD Ann: Appendix 4G and Corporate Governance Statement
	BOD BOD Ann: Notice of Annual General Meeting/Proxy Form
	BOD BOD Ann: Quarterly Activities Report and Appendix 4C
	BOD BOD Ann: CEO presentation to South-West Connect Showcase
	BOD BOD Ann: International patent application filed by Bod
	BOD BOD Ann: Date of Annual General Meeting
	BOD BOD Ann: Section 708A(5) cleansing notice
	BOD BOD Ann: Application for quotation of securities - BOD
	BOD BOD Ann: Notification regarding unquoted securities - BOD
	BOD BOD Ann: Amended Change of Director's Interest Notice - George Livery
	BOD BOD Ann: Change of Director's Interest Notice - David Baker
	BOD BOD Ann: Change of Director's Interest Notice - George Livery
	BOD BOD Ann: Apppendix 2A - Underwriting Offer
	BOD BOD Ann: Sction 708A(5) secondary trading notice
	BOD BOD Ann: Appendix 2A - Shortfall Offer
	BOD BOD Ann: Application for quotation of securities - BOD
	BOD BOD Ann: Successful completion of Entitlement Offer
	BOD BOD Ann: Application for quotation of securities - BOD

Register to track BOD and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.02	0	0.00 (0.00%)
12-Sep	$0.02	0	0.00 (0.00%)
11-Sep	$0.02	0	0.00 (0.00%)
05-Sep	$0.02	0	0.00 (0.00%)
04-Sep	$0.02	0	0.00 (0.00%)
03-Sep	$0.02	0	0.00 (0.00%)
29-Aug	$0.02	0	0.00 (0.00%)
28-Aug	$0.02	0	0.00 (0.00%)
22-Aug	$0.02	0	0.00 (0.00%)
21-Aug	$0.02	0	0.00 (0.00%)
15-Aug	$0.02	0	0.00 (0.00%)
14-Aug	$0.02	0	0.00 (0.00%)
07-Aug	$0.02	0	0.00 (0.00%)
31-Jul	$0.02	0	0.00 (0.00%)
30-Jul	$0.02	0	0.00 (0.00%)
0 up, 0 down, and 15 flat days